Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease

Free Radical Biology and Medicine

Volumn 48, Issue 2, 2010, Pages 318-324

  Zahid, Muhammad ^a   Saeed, Muhammad ^a   Rogan, Eleanor G ^a   Cavalieri, Ercole L ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

1,4 Michael addition; Catechol quinones; Depurinating DNA adducts; Kinetics of depurination

Indexed keywords

BENZENE; CATECHOL QUINONE; DEOXYGUANOSINE; DOPAMINE; ESTROGEN; MONOPHENOL MONOOXYGENASE; N ACETYLDOPAMINE; NAPHTHALENE; QUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYCLIZATION; DEGENERATIVE DISEASE; DNA ADDUCT; MICHAEL ADDITION; PH; PRIORITY JOURNAL;

AMINOBUTYRIC ACIDS; ANIMALS; BENZENE; CATECHOLS; CATTLE; CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; DOPAMINE; HUMANS; HYDROGEN-ION CONCENTRATION; MUTAGENESIS; MUTAGENS; NAPHTHALENES; NEOPLASMS; NEURODEGENERATIVE DISEASES; QUINONES;

EID: 72649092754     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.11.002     Document Type: Article

References (22)

1. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., Muti P., Rogan E., Russo J., Santen R., and Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta 1766 (2006) 63-78
2. Cavalieri E., and Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann. N. Y. Acad. Sci. 1089 (2006) 286-301
3. Stack D.E., Li G., Hill A., and Hoffman N. Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones. Chem. Res. Toxicol. 21 (2008) 1415-1425
4. Chakravarti D., Mailander P.C., Li K.M., Higginbotham S., Zhang H.L., Gross M.L., Meza J.L., Cavalieri E.L., and Rogan E.G. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20 (2001) 7945-7953
5. Mailander P.C., Meza J.L., Higginbotham S., and Chakravarti D. Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 101 (2006) 204-215
6. Saeed M., Zahid M., Gunselman S.J., Rogan E., and Cavalieri E. Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3′,4′-quinone: implications for mutagenic activity. Steroids 70 (2005) 29-35
7. Saeed M., Gunselman S.J., Higginbotham S., Rogan E., and Cavalieri E. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3′,4′-quinone or enzyme-activated 3′-hydroxyhexestrol: implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens. Steroids 70 (2005) 37-45
8. Saeed M., Rogan E., and Cavalieri E. Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int. J. Cancer 124 (2009) 1276-1284
9. Saeed M., Higginbotham S., Rogan E., and Cavalieri E. Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA: implications for the mechanism of tumor initiation by naphthalene. Chem. Biol. Interact. 165 (2007) 175-188
10. Saeed M., Higginbotham S., Gaikwad N., Chakravarti D., Rogan E., and Cavalieri E. Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation. Free Radic. Biol. Med. 47 (2009) 1075-1081
11. Cavalieri E.L., Li K.M., Balu N., Saeed M., Devanesan P., Higginbotham S., Zhao J., Gross M.L., and Rogan E.G. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23 (2002) 1071-1077
12. Snyder R., and Kalf G.F.A. perspective on benzene leukemogenesis. Crit. Rev. Toxicol. 24 (1994) 177-209
13. Guengerich F.P., Kim D.H., and Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4 (1991) 168-179
14. Sabourin P.J., Bechtold W.E., Griffith W.C., Birnbaum L.S., Lucier G., and Henderson R.F. Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 99 (1989) 421-444
15. Kalf G.F. Recent advances in the metabolism and toxicity of benzene. Crit. Rev. Toxicol. 18 (1987) 141-159
16. 32P-postlabeling. Carcinogenesis 12 (1991) 1181-1186
17. Levay G., Ross D., and Bodell W.J. Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis 14 (1993) 2329-2334
18. Twerdok L.E., and Trush M.A. Differences in quinone reductase activity in primary bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res. Commun. Chem. Pathol. Pharmacol. 67 (1990) 375-386
19. Huang X., Xu R., Hawley M.D., and Kramer K.J. Model insect cuticle sclerotization: reactions of catecholamine quinones with the nitrogen-centered nucleophiles imidazole and N-acetylhistidine. Bioorg. Chem. 25 (1997) 179-202
20. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., and Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10937-10942
21. Li K.M., Todorovic R., Devanesan P., Higginbotham S., Kofeler H., Ramanathan R., Gross M.L., Rogan E.G., and Cavalieri E.L. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25 (2004) 289-297
22. Zahid M., Kohli E., Saeed M., Rogan E., and Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem. Res. Toxicol. 19 (2006) 164-172